Tambus, Allyza C.
HRN: 22-34-16 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/17/2022
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
12/17/2022
12/24/2022
ORAL
1ml
QID
Oral Ulcer
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes